Pemetrexed garners good response in ALK-rearranged lung cancer - ONA
Links shared publicly online about this topic.
- 0total visits
Pemetrexed garners good response in ALK-rearranged lung cancer - ONA
Pemetrexed (Alimta) appears to be an effective treatment in persons with non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive.
View full resource at oncologynurseadvisor.com
Tags: Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer Medication, Lymphoma, Lung, Alimta
Most Recently Shared on September 21, 2011 at 12:08 pm By:
Pemetrexed garners good response in ALK-rearranged #lung #cancer http://t.co/n6xoR7RB
Advertisement
